- Home
- CRL vs ENSG Comparison
CRL vs ENSG Comparison
Compare CRL & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- ENSG
- Stock Information
- Founded
- CRL 1947
- ENSG 1999
- Country
- CRL United States
- ENSG United States
- Employees
- CRL N/A
- ENSG N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- ENSG Hospital/Nursing Management
- Sector
- CRL Health Care
- ENSG Health Care
- Exchange
- CRL Nasdaq
- ENSG Nasdaq
- Market Cap
- CRL 7.1B
- ENSG 7.3B
- IPO Year
- CRL 2000
- ENSG 2007
- Fundamental
- Price
- CRL $157.12
- ENSG $150.18
- Analyst Decision
- CRL Hold
- ENSG Buy
- Analyst Count
- CRL 14
- ENSG 7
- Target Price
- CRL $186.38
- ENSG $164.71
- AVG Volume (30 Days)
- CRL 859.6K
- ENSG 349.6K
- Earning Date
- CRL 08-06-2025
- ENSG 07-24-2025
- Dividend Yield
- CRL N/A
- ENSG 0.17%
- EPS Growth
- CRL N/A
- ENSG 39.72
- EPS
- CRL N/A
- ENSG 5.30
- Revenue
- CRL $4,022,597,000.00
- ENSG $4,423,354,000.00
- Revenue This Year
- CRL N/A
- ENSG $17.71
- Revenue Next Year
- CRL $2.49
- ENSG $9.69
- P/E Ratio
- CRL N/A
- ENSG $28.34
- Revenue Growth
- CRL N/A
- ENSG 14.81
- 52 Week Low
- CRL $91.86
- ENSG $118.73
- 52 Week High
- CRL $254.15
- ENSG $158.45
- Technical
- Relative Strength Index (RSI)
- CRL 67.60
- ENSG 50.74
- Support Level
- CRL $148.41
- ENSG $147.62
- Resistance Level
- CRL $160.40
- ENSG $155.81
- Average True Range (ATR)
- CRL 4.71
- ENSG 3.13
- MACD
- CRL 0.42
- ENSG -0.92
- Stochastic Oscillator
- CRL 81.08
- ENSG 25.45
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.